Improving community access to terminal phase medicines in Australia: Identification of the key considerations for the implementation of a 'core medicines list'

Paul A. Tait, Weng Hou Cheung, Michael Wiese, Kirsten Staff

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    During the terminal phase, access to medicines is critical for people wishing to spend their last days of life at home. Yet, access to medicines can be problematic. The aim of this study was to report the perspectives of specialist and generalist health professionals (HPs) on the issues of community access to medicines for this vulnerable group. A qualitative descriptive study design investigated the views of HPs working in palliative care roles in South Australia. Nurses, doctors and pharmacists described their experiences of accessing medicines for management of terminal phase symptoms during semi-structured focus group discussions. Content analysis identified six themes including: 'Medication Supply', 'Education and Training', 'Caregiver Burden', 'Safety', 'Funding' and 'Clinical Governance'. Future projects should aim to address these themes when developing strategies for the management of people wishing to die at home.

    Original languageEnglish
    Pages (from-to)373-378
    Number of pages6
    JournalAustralian journal of primary health
    Volume23
    Issue number4
    DOIs
    Publication statusPublished - 11 May 2017

    Keywords

    • Palliative care
    • Medication
    • community access

    Fingerprint Dive into the research topics of 'Improving community access to terminal phase medicines in Australia: Identification of the key considerations for the implementation of a 'core medicines list''. Together they form a unique fingerprint.

    Cite this